ZDZubarev Dmitriy

Zubarev Dmitriy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zubarev Dmitriy has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Early discontinuation of dual antiplatelet therapy after PCI in patients at high bleeding risk: an OCT-guided clinical case

    by A. A. Prokhorikhin, Yu. V. Kukushkina, D. D. Zubarev, A. V. Gorbatykh, K. A. Rzaeva, А. А. Прохорихин, Ю. В. Кукушкина, Д. Д. Зубарев, А. В. Горбатых, К. А. Рзаева

    Background. Optimizing the duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) remains challenging, especially in patients with high bleeding risk and diabetes mellitus, where stent thrombosis risk is significantly increased due to delayed endothelialization. Objective. To demonstrate the safety of early DAPT discontinuation based on individual assessment of stent endothelialization using optical coherence tomography (OCT). Materials and Methods. We present a clinical case of a 71-year-old female with type II diabetes, atrial fibrillation (CHA2DS2-VASc score of 6), functional class II exertional angina, and a history of left anterior descending (LAD) artery stenting. Risk stratification indicated a high hemorrhagic status: HAS-BLED score of 3, PRECISE-DAPT score of 17, ARC-HBR score of 2, and a CRUSADE score of 49 (corresponding to an 11.9 % risk of major bleeding). Baseline OCT revealed significant narrowing: the minimal lumen area in the LAD was 3.51 mm² (56 % area stenosis), and 2.08 mm² in the right coronary artery (RCA) (72 % area stenosis). Stenting of LAD and right coronary artery was performed using amphilimus-eluting polymer-free stents. DAPT discontinuation was planned at 1 month contingent on sufficient endothelialization per control OCT. Results. Follow-up OCT at one month demonstrated neointimal coverage of 81.18 % of the struts in the LAD and 95.9 % in the RCA. No evidence of stent thrombosis or restenosis was observed. The patient was transitioned to clopidogrel monotherapy, alongside ongoing anticoagulant therapy for the prevention of thrombotic complications associated with atrial fibrillation. During the one-year follow-up period, no ischemic or hemorrhagic adverse events were registered, and there was no recurrence of angina symptoms. Conclusion. The application of OCT for the evaluation of stent strut endothelialization provides a robust rationale for shortening DAPT duration to 1 month in patients with high hemorrhagic risk. This strategy minimizes bleeding threats without escalating the incidence of ischemic events, even in the presence of concomitant diabetes mellitus and multiple comorbidities.

  • Open Access

    Trends in intravascular diagnostics development in the Russian Federation: four-year data from the Russian registry on intravascular imaging and physiology methods

    by V. V. Demin, A. M. Babunashvili, D. V. Duplyakov, T. V. Kislukhin, E. Yu. Kostyrin, O. E. Zauralov, A. V. Demin, A. V. Ter-Akopyan, S. A. Dolgov, Z. Kh. Shugushev, et al.

    Aim. To analyze the results of the use and development trends of intravascular diagnostic methods based on four-year data from the Russian registry on the use of intravascular imaging and physiology methods. Material and methods . In 2024, data on 13125 examinations in 5408 patients were entered into the registry, and the registry includes information on 33154 procedures in 14311 patients. The database design and content continued to be refined, with several sections significantly revised. The most significant changes affected the sections on immediate and late surgical outcomes. To standardize the intravascular imaging evaluation during endovascular interventions, quantitative parameters were introduced, with semi-automated calculation of final coefficients and derivation of final conclusions. Results. Over 4 years, 30 departments from 18 Russian cities participated in the registry. The average number of examinations per patient increased from 1,96 in 2021 to 2,43 in 2024. There is a trend toward an increasing role for intravascular ultrasound, with a decline in the use of optical coherence tomography and, to a lesser extent, fractional flow reserve. The share of intravascular ultrasound increased from 37% to 66%, while optical coherence tomography decreased from 23% to 5%, and fractional flow reserve decreased from 40% to 29%. Approximately 20% of studies were performed for acute coronary syndrome (19% of which were for ST-segment elevation myocardial infarction), while 2% were performed for noncoronary pathology. The largest number of studies were performed at the initial and final stages of surgery, followed by primary diagnostic studies, intraoperative monitoring, and diagnostic studies during patient follow-up. Conclusion . The registry provides an objective means of analyzing intravascular diagnostic methods in Russia. Improving the registry and standardizing approaches to performing and evaluating data from intravascular techniques allows for an objective assessment of intervention results and contributes to their improvement. A number of clinics across the country routinely use intravascular diagnostic techniques, including for acute coronary syndrome and non-coronary pathology.

  • Open Access

    Problem of small left ventricular volume during transcatheter aortic valve replacement: a case series

    by A. A. Prokhorikhin, Yu. V. Kukushkina, D. D. Zubarev, A. V. Gorbatykh, K. B. Lapshin

    Modern treatment of severe aortic valve stenosis includes not only open surgery, but also minimally invasive transcatheter aortic valve implantation (TAVI). However, despite the reduction of periprocedural complications of TAVI with increasing experience of operators, the problem of interventions in patients with small left ventricular volume remains unclear. It is known that with the progression of aortic stenosis, the left ventricle can undergo concentric remodeling with myocardial hypertrophy, which leads not only to a decrease in stroke volume, but also diastolic dysfunction due to increased wall stiffness. As a result, such a left ventricular phenotype, especially in combination with high pulmonary hypertension, is poorly resistant to hemodynamic overload, which carries an increased risk of intraoperative mortality. In our work, we present 3 cases of TAVI in similar patients with a small left ventricular volume, in which various modifications of the intervention algorithms were used.

  • Open Access

    Transcatheter thrombaspiration in acute thrombosis of the superior mesenteric artery

    by N. V. Marukyan, D. B. Nasedkin, O. V. Kornyushin, V. M. Vetra, A. V. Gorbatykh, D. D. Zubarev, A. V. Starzhevskaya, E. S. Danilova, M. A. Chernyavsky, A. E. Neimark, et al.

    Background: Acute mesenteric ischemia is a surgical problem characterized by extremely high mortality and doesn`t decrease. Description of a clinical case: Two cases of successful treatment of patients with the background of a severe comorbid diseases in acute thrombosis of the superior mesenteric artery using transcatheter thromboaspiration are presented. Results: In the presented clinical cases, minimally invasive treatment was possible. The decision was based on the clinical picture and multispiral computed tomography results, in the absence of clinical and instrumental signs of peritonitis or intestinal wall destruction in MSCT. Despite the successful results, questions for further discussion and study were formulated. Conclusion: Transcatheter thromboaspiration is an effective and safe alternative to open thrombectomy. Postoperative diagnostic laparoscopy is necessary for intraoperative diagnostics of intestinal viability. The timing of diagnostic laparoscopy requires discussion. Today, in patients with suspected acute mesenteric ischemia, with a high level of clinical alertness, the chance for a successful prognosis is based on spiral computed tomography, angiography, endovascular interventions for intestinal revascularization. This treatment should be performed in a multidisciplinary hospital with appropriate technical capabilities, as well as a multidisciplinary team.

  • Open Access

    Efficacy of transcatheter low-dose thrombolysis in patients with intermediate-high risk pulmonary embolism. Study rationale and design

    by M. A. Simakova, S. I. Parkhomenko, K. B. Lapshin, T. D. Glebovskay, D. V. Karpova, K. N. Malikov, Ekaterina Leonidovna Urumova, A. V. Berezina, D. D. Zubarev, N. V. Marukyan, et al.

    Aim. Comparison of conservative and invasive treatment strategies in patients with intermediate-high risk pulmonary embolism (PE) based on a multimodal assessment of efficacy and safety.Material and methods. This single-center, open-label, randomized, comparative trial will include 100 patients with a verified diagnosis of PE with intermediate-high risk of 30-day mortality. Patients will be randomized 1:1 to standard anticoagulant therapy or selective low-dose alteplase transcatheter thrombolysis. Patients will be followed for 12 months. The primary endpoint is a decrease in the right ventricle to left ventricle ratio by 20% or more from baseline at 48±6 hours after initiation of therapy. There are secondary endpoints: patient hemodynamic instability; ISTH major bleeding; Qanadli index decrease at 48 hours; degree of residual thrombosis with reduced perfusion at 3-6 months; incidence of post-thromboembolic syndrome at 3-6 months; 30-day, 90-day, and 1-year mortality.Conclusion. The study will provide important clinical data on the short- and long-term efficacy and safety of different treatment approaches in patients with intermediate-to-high-risk acute pulmonary embolism.


  • Open Access

    A clinical case of successful palliative endovascular treatment of a patient with a single ventricle, mitral valve atresia, an intact atrial septum and persistent cardinal vein

    by Gorbatykh Artem, Manannikov Denis, Ivanilova Alina, Averkin Igor’, Zubarev Dmitriy, Prokhorikhin Aleksei, Soynov Ilya, Grekhov Evgeniy, Chernyavskiy Mikhail

    Background: Treatment of newborns with univentricular hemodynamics in combination with an anomaly of pulmonary venous return has the worst correction results in modern cardiac surgical papers. According to the data obtained by different authors, postoperative mortality in this cohort of patients varies from 41.7 to 53%. The presence of the venous outflow tract obstruction, as well as the serious condition of a newborn, is one of the main factors that increase the risk of death in the postoperative period. Case presentation: This article reveals a clinical case of a patient with a combined heart disease prenatally diagnosed in the form of a functionally single ventricle with a double outlet of the main vessels from it, mitral valve atresia, an intact atrial septum and an anomaly of venous return, when the blood outflow from the left atrium was carried out through a single fetal communication such as stenotic cardinal vein. In order to stabilize the patient's condition, the newborn urgently underwent stenting of the stenotic section of the cardinal vein. However, due to the lack of positive dynamics in the postoperative period, the child underwent repeated endovascular intervention and stenting of the intraoperatively created interatrial communication was performed. Taking into account the absence of obstruction of the outflow tract to the pulmonary artery, it was necessary to perform an open surgical intervention in a short time such as pulmonary artery banding. Conclusions: Thus, palliative endovascular intervention in critically ill neonates with univentricular hemodynamics and anomalous pulmonary venous return can be considered as a method of choice that can become a new safer strategy for managing infants in order to stabilize the condition before the main stage of surgical intervention comes.

  • Open Access

    Creation of atrial communication in patients with pulmonary hypertension: from balloon atrioseptostomy to atrial flow regulator

    by A. V. Gorbatykh, D. A. Manannikov, K. S. Lening, A. A. Prokhorikhin, D. D. Zubarev, M. A. Chernyavskiy, N. S. Goncharova, O. M. Moiseeva

    Pulmonary hypertension (PH) affects about 1 % of the world’s population, with a three-year survival rate of 70 %. The pathogenetic causes of death are the remodeling of the pulmonary arteries (PA) and the development of right ventricular heart failure (HF), therefore, the main goal of the treatment of pulmonary arterial hypertension (PAH) is to relieve the right chambers of the heart by reducing the pressure in the PA. For this purpose, it is possible to prescribe specific drug therapy to the patient, and in severe cases, surgical intervention — lung transplantation or cardiopulmonary organ complex. However, recently, due to the development and improvement of endovascular methods of treatment of PH, palliative endovascular interventions on the atrial septum are increasingly used, which have undergone significant changes over the past decades. This article presents a literature review of all currently available palliative X-ray endovascular methods for the treatment of PAH, as well as PH developed in patients with left ventricular HF. Objective. The purpose of the review is to assess the role of X-ray endovascular intervention in the treatment of PH.

  • Open Access

    Successful transcatheter aortic valve replacement in a patient with radiation-induced aortic stenosis

    by D. D. Zubarev, S. V. Sim, V. S. Krasnov, A. V. Gorbatykh, M. A. Chernyavsky, A. A. Prokhorikhin

    Aortic stenosis is one of the most common valvular heart defects that occurs in patients with oncology after radiation therapy and requires surgical treatment. However, this group of patients has a higher risk of intra- and postoperative complications, and therefore the most optimal method of surgical treatment of aortic stenosis in such a cohort of patients is transcatheter aortic valve implan­tation (TAVI).Brief description. Forty-six-year old woman entered the Almazov National Medi­cal Research Center with a clinical picture of severe aortic stenosis. At a young age, the patient was diagnosed with lymphogranulomatosis, or Hodgkin’s disease, for which radiation therapy was performed, which was complicated in the long term by valvular pathology. After a thorough examination, a high intraoperative risk for the patient was determined by the cardiac team and endovascular treatment of severe aortic stenosis was performed. The postoperative period was complicated by the development of complete atrioventricular block, which caused the implantation of a permanent dual-chamber pacemaker.Discussion. The presented case is an example of successful surgical treatment of aortic stenosis associated with previous radiation therapy for Hodgkin’s disease in a patient.Conclusion. Endovascular aortic valve implantation is a promising approach to the treatment of patients with post-radiation aortic stenosis, since it is associated with unfavorable anatomical and clinical risk factors for surgical valve replacement. Despite their younger age, these patients represent a category of higher surgical risk. Therefore, additional attention should be paid to the planning of the procedure and the prevention of the main TAVI risks.


  • Open Access

    Pulmonary embolism: options for interventional treatment in the intermediate-high risk group

    by S. I. Parkhomenko, K. B. Lapshin, T. D. Glebovskaya, K. N. Malikov, N. V. Marukyan, D. D. Zubarev, D. V. Alekseeva, O. M. Moiseeva, M. A. Simakova

    Selective transcatheter thrombolysis (STT) in patients with pulmonary embolism (PE) with an intermediatehigh risk of 30-day mortality is an option for rapid lung reperfusion with a decrease in right ventricular (RV) afterload, which largely determines the prognosis of patients.Objective. Comparison of the efficacy of STT using reduced doses of alteplase and routine conservative treatment of patients with PE with an intermediate-high risk of 30-day mortality using a retrospective analysis of the data from Almazov National Medical Research Centre.Design and methods. The retrospective single-center study included 45 patients (18 men (40 %) and 27 women (60 %)) admitted to the anaesthesiology and resuscitation department of the Almazov National Medical Research Centre from January 1, 2021 to May 1, 2022 with the confirmed diagnosis of acute PE. Intermediate-high risk patients (22 people (57,9 %)) were divided into two groups according to the treatment strategy: the group receiving standard anticoagulant therapy (n = 15 (68,2 %)) and the group with STT by alteplase at a total dose of 50 mg (n = 7 (31,8 %)). In order to assess the effectiveness of treatment, the main laboratory and instrumental indicators were compared based on data from the medical information system.Results. Baseline clinical characteristics of the compared groups did not differ. Systolic pressure in the pulmonary artery (SPPA) in the transcatheter treatment group decreased from 59 [50; 82] to 35 [30; 65] mmHg; in the conservative treatment group: from 65 [50; 70] to 52 [40; 59] mmHg. In the selective thrombolysis group, there was a significant trend for a greater decrease SPPA compared to the anticoagulant therapy group: –25 [–29; –3] versus — 10 [–23; –6] mmHg, р = 0,047. There was a significant change in the level of leukocytes and platelets in the group of transcatheter treatment versus anticoagulant therapy: –5,0 [6,1; 4,1] × 109/l vs –2,8 [4,3; 1,8] × 109/l (p = 0,017) and 130 [32; 181] × 1012/l vs 31 [2; 56] × 1012/l (р = 0,044). There were no significant differences in the change in the RV size between the groups. The groups did not differ in the total number of hemorrhagic complications. When bleeding was divided by severity (according to the TIMI classification), moderate bleeding was more common in the selective thrombolysis group (2 cases versus 0 with a conservative approach, p = 0,014). There were no differences in the duration of treatment in the anaesthesiology and resuscitation department and the terms of inpatient treatment.Conclusions. A single center retrospective study demonstrated the high quality of approaches to the diagnosis and treatment of PE in terms of current guidelines. The STT with reduced doses of alteplase was associated with a more significant decrease SPPA and normalization of hemogram parameters when compared to the standard treatment approach. At the same time, selective thrombolysis was associated with a higher risk of hemorrhagic complications. A prospective study of the efficacy and safety of prolonged STT with the selection of the dose of thrombolytic in patients with PE with an intermediate-high risk of 30-day mortality is needed.


  • Open Access

    TAVISCORE: a computer program for risk stratification of complications after aortic valve interventions in patients with reduced ejection fraction

    by D. A. Strelkov, D. D. Zubarev, A. S. Pischugin, V. V. Guryev, D. I. Kulikov, Z. N. Postnikova, K. S. Lening

    Aim. To demonstrate the TAVISCORE program designed to stratify the risk of complications after aortic valve (AV) interventions in patients with reduced ejection fraction.Material and methods. For the period from 2015-2022 at the Almazov Federal North-West Medical Research Center, 128 interventions on AV were performed for aortic stenosis in patients with reduced ejection fraction as follows: 61 — surgical AV replacement (SAVR), 67 — transcatheter aortic valve implantation (TAVI). To create an interactive calculator TAVISCORE (link for free download: https://drive.google.com/file/d/1a3s2MK6Tpk0cIQ_aMB7xe63upEwJsJOh/view?usp=sharing) all patients were combined into one group. For each factor present in the patient, the prognostic coefficient, its contribution to the likelihood of an event in the long-term follow-up period (death, myocardial infarction, stroke), was calculated. The next step, based on the calculations obtained and using the Python 3.10.6 language, was the creation of the TAVISCORE program.Results. The TAVISCORE was created for the personalized choice of tactics for the treatment of patients with aortic stenosis. It contains 54 risk factors and makes it possible to determine probability of cardiac or non-cardiac events in the long-term follow-up period after SAVR and TAVI. Thus, a tactic with lower probability of a complication can be chosen as optimal in this particular case. Retrospective use of the TAVISCORE after surgery can identify patients at high risk of complications, which will allow them to be selected for more thorough management and more frequent screening.Conclusion. The TAVISCORE can be used by a multidisciplinary consensus to select the treatment tactics and stratify the risk of complications after different AV replacement variants in patients with a reduced ejection fraction. Further prospective testing of this program is required.